Trading on traditional medicines

Article metrics

Developing countries could exploit traditional medicine to kick-start biotech, but only if their products measure up to the demands of Western regulators. Paroma Basu reports.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    World Health Organization Secretariat. Traditional Medicine (WHO, Fifty-Sixth World Health Assembly, A56/18, March 31, 2003) (http://www.who.int/gb/EB_WHA/PDF/WHA56/ea5618.pdf).

  2. 2

    Center for Drug Evaluation and Research, US Food and Drug Administration. Guidance for Industry Botanical Drug Products. Fed. Register 65, 49247–49248, 2000. (http://www.fda.gov/cder/guidance/1221dft.pdf).

  3. 3

    European Parliament. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. (Official J. Eur. Commun., L311, 67–128, 2001. (http://europa.eu.int/eur-lex/pri/en/oj/dat/2001/l_311/l_31120011128en00670128.pdf).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Basu, P. Trading on traditional medicines. Nat Biotechnol 22, 263–265 (2004) doi:10.1038/nbt0304-263

Download citation

Further reading